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Abstract：Periodontal diseases cause an inflammation and degradation of periodontal tissues and 
missing of teeth. The incidence rate of periodontal diseases is high in middle-aged and elderly people. 
A reasonable diagnosis of periodontal diseases is very important to keep teeth, however, conventional 
examinations of periodontal diseases is not necessarily exact and objective. Gingival crevicular ﬂuid 
(GCF) is an exudate secreted from periodontal tissues and contains many components including 
proteolytic enzymes, inflammatory cytokines, blood-associated proteins, cellular and bacterial 
fragments. Because some proteins in GCF are related to inflammation, tissue degradation and bone 
metabolism, those proteins have been studying as a diagnostic marker of periodontal diseases. GCF is 
noninvasively collected using a sterile paper strip and biomarkers are determined using enzyme-linked 
immunosorbent assay (ELISA) and enzyme activity assay. We identiﬁed calprotectin, an inﬂammation-
related protein, in GCF and calprotectin level in GCF from periodontitis sites was signiﬁcantly higher than 
that of healthy control. Calprotectin level in GCF was positively correlated to gingival index and other 
biomarkers and decreased by periodontal treatments. Resistin is an adipocytokine and its level increases 
in some inﬂammatory diseases. Resistin level in GCF from periodontitis sites was high compared to the 
level of healthy control samples. Procollagen type I C-terminal peptide (PICP) is a biomarker for bone 
metabolism and its level was high in GCF collected from periodontitis sites. These results suggested 
that calprotectin, resistin and PICP are useful biomarkers for periodontal diseases. On the other hand, 
we showed that glycated albumin (GA), a marker of diabetes mellitus (DM), was contained in GCF 
and GA level in GCF from DM patients was significantly higher than that of non-DM individuals. 
Components in GCF may be biomarkers of systemic diseases as well as periodontal diseases and their 
determination will be useful diagnostic examination of some diseases. Recently, we have been studying 
the determining system of GCF calprotectin, including microchip ELISA, surface plasmon resonance 
assay and immuno-chromatography assay. When GCF biomarkers are determined using the determining 
systems, we will simply, exactly and objectively diagnose periodontal diseases at our dental ofﬁces.
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室では，GCF採取後，その液量を Periotron 8000 （Harco 
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